Nir Nimrodi
Directeur/Membre du Conseil chez EVOGENE LTD.
Fortune : - $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Ofer Haviv | M | 58 | 22 ans | |
| Julien Meissonnier | M | - |
Accellix, Inc.
 Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 15 ans |
| Tatyana Yosef | F | 41 | 15 ans | |
| Sassi Masliah | M | - | 13 ans | |
| Sarit Firon | F | 58 | 8 ans | |
| Adrian Percy | M | 59 | 5 ans | |
| Harvey Kasdan | M | - |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 15 ans |
| Vinita Deshbandhu Gupta | F | 56 | 7 ans | |
| Oded Shoseyov | M | 67 | 6 ans | |
| Benad Goldwasser | M | 73 | 5 ans | |
| Leon Recanati | M | 76 | 19 ans | |
| Zeev Vurembrand | M | 73 | 3 ans | |
| James Turley | M | 68 | 10 ans | |
| Dan Falk | M | 79 | 3 ans | |
| Fred Hassan | M | 78 | 8 ans | |
| Jeffrey Perez | M | 52 | 10 ans | |
| Inbal Kreiss | F | 57 | 3 ans | |
| Charles Piazza | M | - |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 5 ans |
| Eyal Ronen | M | - | 2 ans | |
| Yehu Ofer | M | 59 | 2 ans | |
| Kfir Granit | M | - | 1 ans | |
| Liat Foigel Wejgman | F | - | 9 ans | |
| Michael Reynier | M | - |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | - |
| Barry Zubrow | M | 70 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | - |
| Mark Kapel | M | 48 | 19 ans | |
| Nir Arbel | M | - | 3 ans | |
| Steven M. Harasym | M | - | 6 ans | |
| Yisrael Gewirtz | M | 47 | - | |
| Yaron Eldad | M | 57 | 2 ans | |
| Mark Chess | M | 45 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 11 ans |
| Moshe Arkin | M | 69 | 3 ans | |
| Seymour Liebman | M | 74 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 10 ans |
| Eli Israeli | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Samuel Broder | M | 79 | 2 ans | |
| Sam Donnerstein | M | 71 | 4 ans | |
| Lior Amit | M | 58 | 4 ans | |
| Thomas Shrader | M | - | - | |
| Eyal Emmanuel | M | 51 | 4 ans | |
| Larry D. Horner | M | 90 | 7 ans | |
| Christopher Basta | M | - | - | |
| Chris Savile | M | - | 4 ans | |
| Amir Govrin | M | 57 | 4 ans | |
| Thomas Bostick | M | 67 | 3 ans | |
| Helen Sabzevari | M | 62 | - | |
| Shoshie Katz | F | - |
Proneuron Biotechnologies, Inc.
 Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | 3 ans |
| Andy Bass | M | - | - | |
| Jack Anthony Bobo | M | 58 | - | |
| Olivier R. Jarry | M | 63 | - | |
| Bala S. Manian | M | 77 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | 2 ans |
| Kelly Huang | M | 55 | - | |
| Ena Chan Cratsenburg | F | - | - | |
| Geno Germano | M | 63 | 1 ans | |
| Peter Emtage | M | - | - | |
| Hadyn Parry | M | - | - | |
| Peter Seufer-Wasserthal | M | - | 5 ans | |
| Joel A. Liffmann | M | 63 | 4 ans | |
| Krish S. Krishnan | M | 59 | 5 ans | |
| Andrew Last | M | 64 | 1 ans | |
| Suma M. Krishnan | F | 59 | 4 ans | |
| Gregory Ian Frost | M | 52 | 1 ans | |
| Jeremy Rome | M | - |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 36 | 59,02% |
| Israël | 25 | 40,98% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Nir Nimrodi
- Réseau Personnel